Investigating new treatments for ovarian cancer to improve patient survival
HCC Ovarian Cancer SPORE
This study is looking at new treatments for ovarian cancer to help women who struggle with current therapies, and it aims to find out which patients will benefit the most from these new options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10925273 on NIH RePORTER |
What this research studies
This research focuses on ovarian cancer, a condition with a high mortality rate among women. It aims to address the challenges of treatment resistance that patients often face with current therapies like chemotherapy and PARP inhibitors. The project includes clinical trials testing new agents designed to overcome these resistances, while also identifying which patients are most likely to benefit from these therapies. By combining innovative treatment approaches, the research seeks to enhance patient outcomes and survival rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with ovarian cancer who are experiencing resistance to standard therapies.
Not a fit: Patients with early-stage ovarian cancer who have not yet undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for ovarian cancer, improving survival rates for patients.
How similar studies have performed: Previous research has shown promise in using targeted therapies to overcome treatment resistance in various cancers, suggesting potential success for this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Buckanovich, Ronald J — University of Pittsburgh at Pittsburgh
- Study coordinator: Buckanovich, Ronald J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.